Sugi Predict

Sugi Predict / Compounds / Diphenylether

Diphenylether

Diphenylether

SCHEMBL474226

C=CC=C.c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 7/20 0.71
▸ TSHR P16473 1/20 0.71
▸ NR1H2 P55055 1/20 0.52
▸ BAX Q07812 1/20 0.52
▸ MAOA P21397 1/20 0.52
▸ TGM2 P21980 1/20 0.48
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ MAOB P27338 1/20 0.46
▸ GAA P10253 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ GSTP1 P09211 1/20 0.43
▸ SOS1 Q07889 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ PARP10 Q53GL7 1/20 0.43
▸ PLA2G2A P14555 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylether SCHEMBL22729153 0.97 LTA4H (0.67) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL1219104 0.86 LTA4H (0.67) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL15334207 0.86 LTA4H (0.67) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL21050498 0.86 LTA4H (0.67) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL14657075 0.84 LTA4H (0.86) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL1718434 0.84 LTA4H (0.86) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL12286 0.84 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL9061108 0.84 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL4950525 0.84 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL2461810 0.84 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103261179-B Prepare the method for divinylarene oxide DOW GLOBAL TECHNOLOGIES LLC (US) 2016-01-20 — — CN claimed
US-20080250739-A1 FOAMED PLASTIC STRUCTURES NOVA CHEMICALS INC. (US) 2008-10-16 — — US claimed
WO-2008057705-A1 FOAMED PLASTIC STRUCTURES NOVA CHEMICALS INC. (US) 2008-05-15 — — WO claimed
WO-2008057665-A1 FOAMED PLASTIC STRUCTURES NOVA CHEMICALS INC. (US) 2008-05-15 — — WO claimed
US-20080107852-A1 Foamed plastic structures NOVA CHEMICALS INC. 2008-05-08 — — US claimed
CN-1172722-C Heterogeneous foam materials ���޿��غ͸ʱ�����˾ 2004-10-27 — — CN claimed
CN-1091449-C Foams for absorbent members of catamenial pads prepared from high internal phase emulsions PROCTER & GAMBLE (US) 2002-09-25 — — CN claimed
US-20020128338-A1 Foam materials and high internal phase emulsions made using oxidatively stable emulsifiers PROCTER & GAMBLE COMPANY, THE 2002-09-12 — — US claimed
US-6444716-B1 EMULSIFIER IS PARTIALLY DEHYDRATED REACTION PRODUCT OF: A HYDROCARBYL SUBSTITUTED SUCCINIC ACID OR ANHYDRIDE, AND A POLYAMINE, HYDROXYAMINE OR MIXTURES THE PROCTER & GAMBLE COMPANY 2002-09-03 — — US claimed
CN-1300306-A Abrasion resistant polymeric foam and staln receivers made therefrom PROCTER & GAMBCE COMPANY (US) 2001-06-20 — — CN claimed
CN-1299292-A High suction polymeric foam materials PROCTER & GAMBLE (US) 2001-06-13 — — CN claimed
CN-1217663-A Heterogeneous foam materials PROCTER & GAMBLE (US) 1999-05-26 — — CN claimed
CN-1183728-A Absorbent foams made from high internal phase emulsions for absorbing aqueous fluids PROCTER & GAMBLE (US) 1998-06-03 — — CN claimed
CN-1177966-A Absorbent foams made from high internal phase emulsiona useful for acquiring and distributing aqueous fluids PROCTER & GAMBLE (US) 1998-04-01 — — CN claimed
CN-1177359-A Foams made form high internal phase emulsions useful as absorbent members for catamenial pads PROCTER & GAMBLE (US) 1998-03-25 — — CN claimed
CN-1175959-A Foam material for absorbing aqueous fluids made from high internal phase emulsions having very high water to oil ratios PROCTER & GAMBLE (US) 1998-03-11 — — CN claimed
CN-1175911-A Recycling of prepared high internal phase emulsions in a continuous process PROCTER & GAMBLE (US) 1998-03-11 — — CN claimed
US-4250052-A Catalyst structure and a process for its preparation CHEMICAL RESEARCH & LICENSING COMPANY (US) 1981-02-10 — — US claimed
US-10626072-B2 Method of preparing methyl tert-butyl ether LG CHEM, LTD. (KR) 2020-04-21 — — US disclosed
CN-85108961-A The separation method of composite porous and production method and metallic element — 1986-06-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626072-B2 Method of preparing methyl tert-butyl ether TERT, TAF5, TECR LTA4H 1078/4885TSHR 551/4885NR1H2 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.